Research Insight
Research Insight
New Research System Finds & Targets Vulnerabilities in Lung Cancer Cells
Genetic changes that help lung cancer thrive also make it vulnerable to a promising experimental drug, according to a study led by researchers from Perlmutter Cancer Center at NYU Langone Health, and published online October 2 in Nature Medicine.
Specifically,...
Research Insight
Breaking bad: cancer cell drug addiction solved
Cancer cells can become not only resistant but also addicted to the drugs that serve to kill them. A research team led by professor Daniel Peeper from the Netherlands Cancer Institute has now discovered the underlying mechanism, which may...
Research Insight
Advancing collaboration in healthcare through technology, information, and data at HIMSS AsiaPac17
The 11th HIMSS AsiaPac17 Conference and Exhibition was designed to cast a spotlight on understanding the ever-evolving influence that technology,information and data have in an increasingly growing connected ecosystem of health, and how this is enabling greater collaboration between governments, healthcare...
Research Insight
The Parker Institute and Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced the first patients have begun treatment in a new pancreatic cancer multi-center clinical trial. To combat the nation’s third deadliest cancer, the phase 1b/2 open-label study will explore...
Research Insight
Poliovirus Therapy Induces Immune Responses Against Cancer
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body’s own capacity to fight malignancies by activating an inflammation process that counter’s the ability of cancer cells to evade the immune system.
Describing this process...
Research Insight
New University of California Cancer Consortium to tackle state’s second leading cause of death
The University of California’s five academic cancer centers, home to some of the world’s leading scientists and physicians, have formed a consortium to better address California’s most pressing cancer-related problems and opportunities, UC President Janet Napolitano and Dr. John...
Research Insight
New biomarker predicts metastatic prostate cancers
Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to treat and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read